Partner/Owner
Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Hugh Goodfellow has worked on the following 93 EPO patent applications which have been published in the last five years:

EP11718186

ENGINEERED PLANT CYSTEINE PROTEASES AND THEIR USES

IPC classification:
C07K 14/08, C12N 9/50, C12N 15/37
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11720156

UBIQUITINATION ASSAY

IPC classification:
C12Q 1/37, G01N 33/542, G01N 33/68
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP10849756

BIOFUEL PRODUCTION

IPC classification:
C12N 9/30, C12N 9/34, C12P 7/06, C12P 19/14, C12P 19/20, C12R 1/865
Applicant:
University of Padova (Universita degli Studi di Padova)
Applicant:
Stellenbosch University
Agent:
Alain Zimmermann, Cabinet Malemont
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP12177827

Production and purification of recombinant arylsulfatase A

IPC classification:
A61K 38/46, A61P 25/00, C12N 9/16
Agent:
Plougmann & Vingtoft A/S
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11835385

THERAPEUTIC COMPOSITIONS FOR DIABETIC SYMMETRICAL POLYNEUROPATHY

IPC classification:
A61K 31/46, A61K 31/496, A61K 31/5513, A61P 25/02, C07D 417/12, C07D 451/10, C07D 471/04, C07D 495/04
Applicant:
University of Manitoba
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12178712

Human salty taste receptor and methods of modulating salty taste perception

IPC classification:
C07K 1/00, C07K 14/705, G01N 33/554, G01N 33/566, G01N 33/68, G01N 33/84
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11848160

COMPOSITIONS AND METHODS FOR SPINE FUSION PROCEDURES

IPC classification:
A61B 17/58
Agent:
Lavoix Munich
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP12170345

Stem cells derived from the carotid body and uses thereof

IPC classification:
A61K 35/30, C12N 5/079
Applicant:
Universidad de Sevilla - Oficina de Transferencia de Resultados de Investigación (OTRI)
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12739329

PATHOGENIC MYCOBACTERIA-DERIVED MANNOSE-CAPPED LIPOARABINOMANNAN ANTIGEN BINDING PROTEINS

IPC classification:
A61K 39/40, A61P 31/06, C07K 16/12, G01N 33/569
Applicant:
National University of Singapore
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12707954

ADVANCED ACTIVE LIPOSOMAL LOADING OF POORLY WATER-SOLUBLE SUBSTANCES

IPC classification:
A61K 9/127, A61K 47/48
Agent:
Nederlandsch Octrooibureau N.V.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13156603

Hyperphotosynthetic organisms

IPC classification:
C12N 1/21, C12N 9/00, C12N 15/53
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12785579

PROCESS FOR PURIFYING HEPARAN-N-SULFATASE

IPC classification:
A61K 38/47, C12N 9/24
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Graham James Lock, Fry Heath & Spence LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12728007

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

IPC classification:
A61K 31/131, A61K 31/132, A61K 31/215, A61K 31/56, A61K 38/00, A61K 38/16, A61K 38/43
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12729758

MCAM ANTAGONISTS AND METHODS OF TREATMENT

IPC classification:
C07K 16/30
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11735930

A METHOD OF PREDICTING CLINICAL OUTCOMES FOR MELANOMA PATIENTS USING CIRCULATING MELANOMA CELLS IN BLOOD

IPC classification:
G01N 33/574
Applicant:
Janssen Diagnostics, LLC
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11848839

HUMAN MONOCLONAL ANTIBODY WITH SPECIFICITY FOR DENGUE VIRUS SEROTYPE 1 E PROTEIN AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/42, A61K 45/06, A61P 31/14, C07K 16/10, C12N 15/13, C12P 21/08
Applicant:
National University of Singapore
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12818250

PENTRAXIN 3 ASSOCIATION WITH ASTHMA

IPC classification:
G01N 33/48
Applicant:
Janssen Biotech, Inc.
Applicant:
The Regents of the University of Michigan
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12710838

COMBINATION THERAPIES FOR HEMATOLOGIC MALIGNANCIES

IPC classification:
A61K 31/4184, A61K 31/4439, A61K 31/52, A61K 39/00, A61K 45/06, A61P 35/00, A61P 35/02
Applicant:
Gilead Calistoga LLC
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP12714910

METHODS AND COMPOSITIONS FOR NORMALIZATION OF TUMOR VASCULATURE BY INHIBITION OF LOXL2

IPC classification:
A61K 31/7088, C07K 16/40
Applicant:
Gilead Biologics, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11845391

TREATMENT OF JAK2-MEDIATED CONDITIONS

IPC classification:
A61K 31/444, A61K 31/505, A61K 31/506, A61K 31/5377, A61K 31/541, A61P 7/06
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Joseph Lenthall, Mewburn Ellis LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP12172222

LOX AND LOXL2 INHIBITORS ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00
Applicant:
Gilead Biologics, Inc.
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12828354

PROCESS FOR RECOVERING SALT DURING A LIGNOCELLULOSIC CONVERSION PROCESS

IPC classification:
C02F 1/04, C02F 1/52, C05F 5/00, C05F 7/00, C12P 7/10, C12P 19/00, D21C 9/00, F22B 1/00, F22B 33/18
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP11740450

ANTIBODIES THAT BIND TO LYSYL OXIDASE-LIKE 2 (LOXL2) AND METHODS OF USE THEREFOR

IPC classification:
A61K 39/395, C07K 16/40
Applicant:
Gilead Biologics, Inc.
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Lars Höglund, Albihns.Zacco AB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12836507

COMPOUNDS FOR IMPROVED VIRAL TRANSDUCTION

IPC classification:
C12N 5/02, C12N 5/071, C12N 7/01
Applicant:
Bluebird Bio, Inc.
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11838922

A2A ANTAGONISTS AS COGNITION AND MOTOR FUNCTION ENHANCERS

IPC classification:
A61K 9/00, A61K 31/198, A61K 31/44
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11725852

METHODS OF TREATING HEMATOLOGICAL DISORDERS WITH QUINAZOLINONE COMPOUNDS IN SELECTED PATIENTS

IPC classification:
A61K 31/517, A61K 31/52, A61P 35/02
Applicant:
Gilead Calistoga LLC
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11724493

PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF

IPC classification:
A61K 31/47
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12847487

ANTISENSE OLIGONUCLEOTIDE MODULATORS OF SEROTONIN RECEPTOR 2C AND USES THEREOF

IPC classification:
C07H 21/00, C12N 15/113
Applicant:
Shire Human Genetic Therapies Inc
Applicant:
University of Kentucky
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11700973

EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT

IPC classification:
A61K 38/16, A61P 31/16
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11760822

PRODRUGS OF GUANFACINE

IPC classification:
A61K 31/155, C07C 279/24, C07D 233/64
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11860324

NON-AQUEOUS HIGH CONCENTRATION REDUCED VISCOSITY SUSPENSION FORMULATIONS OF ANTIBODIES

IPC classification:
A61K 9/00, A61K 9/10, A61K 9/14, A61K 9/19, A61K 38/38, A61K 39/395, A61K 47/26, A61K 47/42, A61K 47/44
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13197830

Fuel composition comprising a mixture of n-alkanes

IPC classification:
C07C 11/02, C10L 1/02, C12N 1/21, C12N 9/02, C12N 9/04, C12N 9/88, C12P 5/02, C12P 7/04
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12860175

REACTIVE OXYGEN SPECIES-RESISTANT MICROORGANISMS

IPC classification:
C07H 21/04, C12N 1/20, C12N 1/21, C12N 15/31, C12N 15/52, C12P 7/06
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14173039

Therapeutic compounds

IPC classification:
A61K 31/196, A61K 31/4192, A61K 31/426, A61K 31/435, A61K 31/5375, A61P 9/10, A61P 11/00, A61P 13/12, A61P 17/02, A61P 29/00, A61P 35/00, A61P 43/00, C07C 231/02, C07C 235/38, C07D 213/16, C07D 213/643, C07D 253/04, C07D 261/08, C07D 295/03
Agent:
Ström & Gulliksson AB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14163968

Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters

IPC classification:
A61K 31/443, A61P 11/00, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12794811

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

IPC classification:
A61K 31/405, A61K 31/553, A61P 1/00, A61P 3/00, A61P 11/00, A61P 25/00, A61P 27/00, A61P 35/00, C07D 405/12, C07D 405/14, C07D 498/04
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11718598

PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF

IPC classification:
A61K 31/404, A61K 31/443, A61K 31/4704
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11718596

PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF

IPC classification:
A61K 31/404, A61K 31/443, A61K 31/4704
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11718597

PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF

IPC classification:
A61K 31/404, A61K 31/443, A61K 31/4704
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12196511

Process for producing cycloalkylcarboxiamido-pyridine benzoic acids

IPC classification:
C07D 213/73, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11821115

USE OF INTERLEUKIN-22 IN TREATING VIRAL HEPATITIS

IPC classification:
A61K 38/20, A61P 1/16, A61P 31/12, C07K 14/54
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14168373

Modulators of CFTR

IPC classification:
A61K 31/444, A61P 11/00, A61P 37/00, C07D 401/04, C07D 405/14
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12787303

USE OF (N- [2, 4 -BIS (1, 1 -DIMETHYLETHYL) - 5 - HYDROXYPHENYL]- 1, 4 - DIHYDRO - 4 - OXOQUINOLINE - 3 - CARBOXAMIDE) FOR TREATING CFTR MEDIATED DISEASES

IPC classification:
A61K 31/47
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP13741481

GENERATION OF PHOTORECEPTORS FROM HUMAN RETINAL PROGENITOR CELLS USING POLYCAPROLACTONE SUBSTRATES

IPC classification:
A01N 63/00, A61F 2/00, C12N 5/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13703243

FORMULATIONS OF 3-(6-(1-(2.2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/28, A61K 31/443, C07D 213/75, C07D 405/12, C07D 405/14
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13708625

PHARMACEUTICAL COMPOSITION AND ADMINISTRATION THEREOF

IPC classification:
A61K 9/16, A61K 31/47, A61K 47/02, A61K 47/26, A61K 47/32, A61K 47/38
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13755552

VARIANTS OF PROTHYMOSIN ALPHA AND METHODS OF USING SAME

IPC classification:
A61K 38/00
Agent:
Fabrizio Minoja, Bianchetti Bracco Minoja Srl
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12752152

ASSAYS FOR ANTIBODIES WHICH BIND TO THERAPEUTIC AGENTS

IPC classification:
C12N 11/00, G01N 33/543, G01N 33/68
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Graham James Lock, Fry Heath & Spence LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13778780

HUMAN ANTIBODIES AND SPECIFIC BINDING SEQUENCES THEREOF FOR USE IN STROKE AND ISCHEMIA OR ISCHEMIC CONDITIONS

IPC classification:
A61K 39/395
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Andrew John Teuten, Sagittarius IP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13788302

HETEROMULTIMER CONSTRUCTS OF IMMUNOGLOBULIN HEAVY CHAINS WITH MUTATIONS IN THE FC DOMAIN

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/02, C07K 16/12, C07K 16/24, C07K 16/28, C07K 16/30, C07K 16/46
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11728687

MANIPULATION OF HSP70 AND IRE1ALPHA PROTEIN INTERACTIONS

IPC classification:
C07K 14/00, C07K 16/40, C12N 5/00
Applicant:
National University of Ireland, Galway (National University of Ireland Galway)
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13819634

ANTI-SIGLEC-15 ANTIBODIES

IPC classification:
A61K 39/395, A61P 19/08, C07K 16/28, C12N 5/10, C12N 15/13, C12N 15/85
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
William Gerrit Arends, Marks & Clerk LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP12745098

SOLAR THERMAL ENERGY CAPTURE SYSTEM WITH OVERHEATING PROTECTION AND COLD TEMPERATURE BYPASS

IPC classification:
F24D 17/00, F24D 19/08, F24D 19/10, F24J 2/34, F24J 2/40, F24J 2/46, H02S 40/44
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP13812072

APPARATUS AND METHOD FOR BLOOD COLLECTION

IPC classification:
A61B 5/15
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11764933

ATROPISOMERS OF PI3K-INHIBITING COMPOUNDS

IPC classification:
A61K 31/4985, A61P 29/00, C07D 487/04
Applicant:
Gilead Calistoga LLC
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11792011

AN ENZYMATIC METHOD OF PRODUCING A HYDROGEL FROM XYLAN

IPC classification:
A61K 9/06, A61K 9/48, A61K 9/51, A61K 38/44, A61K 47/36, A61K 47/48, B82Y 5/00, C08B 37/14, C08L 5/14, C12N 11/04, C12N 11/10, C12P 19/04, C12P 19/14
Applicant:
Stellenbosch University
Agent:
Alain Zimmermann, Cabinet Malemont
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13855452

DIGITAL ANALYSIS OF MOLECULAR ANALYTES USING SINGLE MOLECULE DETECTION

IPC classification:
G06F 19/00
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11792012

MODIFICATION OF XYLAN

IPC classification:
C08B 37/14, C09D 105/14, C12P 19/04, D21H 11/20
Applicant:
Stellenbosch University
Agent:
Alain Zimmermann, Cabinet Malemont
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14740167

EVALUATION, ASSAYS AND TREATMENT OF PKAL-MEDIATED DISORDERS

IPC classification:
C12Q 1/56, G01N 33/48, G01N 33/50
Agent:
Potter Clarkson LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14740444

EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS

IPC classification:
C07K 16/40
Agent:
Potter Clarkson LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11733408

METHODS AND COMPOSITIONS FOR TREATING BLEEDING DISORDERS

IPC classification:
A01N 43/04, A61K 31/715, A61K 31/727, A61K 31/737, A61K 38/36, A61K 38/37, A61P 7/00
Applicant:
Baxter International Inc
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Agent:
Stephen John Wilkinson, Stevens Hewlett & Perkins
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14769180

METHODS OF CELL CULTURE

IPC classification:
A61K 39/395
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14776142

METHODS OF CELL CULTURE

IPC classification:
C12N 5/00, C12N 5/02, C12P 1/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14775649

METHODS OF CELL CULTURE

IPC classification:
C12N 5/00, C12N 5/07, C12P 21/04
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14718260

METHOD OF CHARACTERIZING LYSOSOMAL ENZYMES

IPC classification:
C07K 1/26, C12N 9/24
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11748201

PET MONITORING OF AB-DIRECTED IMMUNOTHERAPY

IPC classification:
A61K 51/04
Applicant:
Wyeth LLC
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11711419

SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE

IPC classification:
A61K 31/47, A61P 11/00, C07D 215/56
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP11709600

IMIDAZOPYRIDINES SYK INHIBITORS

IPC classification:
A61K 31/437, A61P 11/00, A61P 19/00, A61P 29/00, A61P 35/00, A61P 35/02, C07D 471/04, C07D 519/00
Applicant:
Gilead Connecticut, Inc.
Agent:
Sam Rogerson Bailey, Mewburn Ellis LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15177547

CANCER THERAPIES AND PHARMACEUTICAL COMPOSITIONS USED THEREIN

IPC classification:
A61K 31/337, A61K 31/4745, A61K 31/475, A61K 31/573, A61K 31/575, A61K 31/70, A61K 31/7088, A61K 39/395, A61K 45/06, A61P 35/00, C07K 16/28
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13167785

Modulators of ATP-binding cassette transporters

IPC classification:
A61K 31/404, A61P 31/00, C07D 405/12, C07D 405/14, C07D 471/04
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10835016

DELIVERY OF MRNA FOR THE AUGMENTATION OF PROTEINS AND ENZYMES IN HUMAN GENETIC DISEASES

IPC classification:
A61K 9/127, A61K 31/7105, A61K 48/00, C07H 21/02
Applicant:
Shire Human Genetic Therapies Inc
Agent:
George William Schlich, Schlich LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14803492

PHARMACEUTICAL COMPOSITIONS COMPRISING PYROPHOSPHATE

IPC classification:
A61K 39/395, A61K 47/42, C01B 25/42
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP10859722

IMMUNOGLOBULIN CLEAVAGE FRAGMENTS VACCINE COMPOSITIONS

IPC classification:
A61K 39/00, C07K 16/06, C07K 16/18, C07K 16/42
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11720157

UBIQUITINATION ASSAY

IPC classification:
C12Q 1/25, G01N 33/50, G01N 33/68
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11722320

POSOLOGY AND ADMINISTRATION OF GLUCOCORTICOID BASED COMPOSITIONS

IPC classification:
A61K 9/20, A61K 31/573, A61P 5/44
Agent:
Simon John Kiddle, Mewburn Ellis LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12700043

TUMOUR CELL AND TISSUE CULTURE

IPC classification:
C12N 5/09, G01N 33/50
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12188920

Pyridyl derivatives as CFTR modulators

IPC classification:
A61K 31/44, A61K 31/4427, A61P 43/00, C07D 213/75, C07D 405/12, C07D 405/14, C07D 413/14
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11799035

CNS DELIVERY OF THERAPEUTIC AGENTS

IPC classification:
A61K 9/00, A61K 9/19, A61K 38/46, A61K 38/47, A61P 25/00, A61P 25/28
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11713134

CRYSTALLINE FORM OF (R)-1(2,2 -DIFLUOROBENZO[D][1,3]DIOXOL-5YL)-N-(1-(2,3-DIHYDEROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2YL)-1H-INDOL-5YL)CYCLOPROPANECARBOXAMIDE

IPC classification:
A61K 31/404, A61P 11/00, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12196539

Process for producing cycloalkylcarboxiamido-pyridine benzoic acids

IPC classification:
C07D 213/73, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12181370

Isoquinoline modulators of ATP-binding cassette transporters

IPC classification:
A61K 31/472, A61K 31/4725, A61P 11/00, C07D 217/22, C07D 401/04, C07D 405/12, C07D 405/14
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12196502

Process for producing cycloalkylcarboxiamido-pyridine benzoic acids

IPC classification:
C07D 213/73, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11745456

PLATELET-DERIVED GROWTH FACTOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF TENDINOPATHIES

IPC classification:
A61P 19/00
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11810502

ANTIFUNGAL AND ANTIPARASITIC POLYENE MACROLIDES

IPC classification:
A61K 9/00, A61K 9/08, A61K 9/20, A61K 31/70, C07D 493/08, C07H 17/08
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP13157678

Compositions suitable for treatment of spinal disease, disorder or condition

IPC classification:
A61K 35/54, A61L 27/36, A61L 27/38, A61L 27/54, C12N 5/071
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP10793116

4 -OXO- 1H -QUINOLINE- 3 - CARBOXAMIDES AS MODULATORS OF ATP -BINDING CASSETTE TRANSPORTERS

IPC classification:
A61K 31/4709, A61P 11/00, C07D 215/56, C07D 401/12, C07D 405/12, C07D 409/12, C07D 413/12, C07D 417/12, C07D 471/08
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Ralph H. Minderop, Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11701541

METHODS & DEVICES FOR DIAGNOSING CARDIAC DISORDERS

IPC classification:
G01N 33/68
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP15709067

PEPTIDES AND METHODS OF USE

IPC classification:
A61K 38/00, C07K 7/08, C07K 14/745
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Agent:
Potter Clarkson LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP10835014

ENZYMATIC ACTIVITY-BASED DETECTION

IPC classification:
G01N 33/53, G01N 33/573
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Caroline Mercedes Carter, Fry Heath & Spence LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15769534

COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC MACULAR EDEMA

IPC classification:
A61K 39/395, A61P 27/02, C07K 16/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15726501

SUBSTRATE-MEDIATED REACTORS FOR BIOASSAYS

IPC classification:
G01N 33/538, G01N 33/543
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16195158

TFPI INHIBITORS AND METHODS OF USE

IPC classification:
A61K 38/18, C07K 14/81
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Agent:
Potter Clarkson LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15831523

MODIFIED IL-2 VARIANTS THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

IPC classification:
A61K 38/20, C07K 14/55, C07K 17/08
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature